Search results for “Cytokine Antibody” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 130 patents, we discovered top 33 key players by total patent application. IBC Pharmaceuticals, Inc., Bioverativ Therapeutics, Inc., Xyphos Biosciences, Inc. are dominant in this area. They take 40.77% of the total patent filing.
IBC Pharmaceuticals, Inc.
New Jersey, United States
Patent: 26
Bioverativ Therapeutics, Inc.
Massachusetts, United States
Patent: 15
STARTUP
Xyphos Biosciences, Inc.
California, United States
Patent: 12
Immunoqure AG
Bayern, Germany
Patent: 9
Merck Patent GmbH
Hessen, Germany
Patent: 9
Lexigen Pharmaceuticals Corp.
Massachusetts, United States
Patent: 5
Sysmex Corp.
Hokkaido, Japan
Patent: 4
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 4
Fidia Farmaceutici SpA
Italy
Patent: 4
Cetus Corp.
California, United States
Patent: 4
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 12 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Xyphos Biosciences, Inc.
California, United States
Patent: 12
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 52 patents applied in the last 5 years. We discover 11 most active companies in this area. The fast-growing Bioverativ Therapeutics, Inc., Xyphos Biosciences, Inc., Rush University Medical Center take 63.46% of patent filing during this period.
Bioverativ Therapeutics, Inc.
Massachusetts, United States
Patent: 15
STARTUP
Xyphos Biosciences, Inc.
California, United States
Patent: 12
Rush University Medical Center
Illinois, United States
Patent: 6
Sysmex Corp.
Hokkaido, Japan
Patent: 4
Novartis AG
Basel-Stadt, Switzerland
Patent: 3
Hangzhou Jiusheng Biotechnology Co., Ltd.
Zhejiang Sheng, China
Patent: 2
Suzhou Tongqian Medical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Weifang Medical University
Shandong Sheng, China
Patent: 1
Xi'an Jiaotong University
Shaanxi Sheng, China
Patent: 1
Beijing Zhengbo Weiye Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 52 patents in last 5 years, we discover 11 new entrants. Bioverativ Therapeutics, Inc., Xyphos Biosciences, Inc., Rush University Medical Center are the most active new entrants in this area.
Bioverativ Therapeutics, Inc.
Massachusetts, United States
Patent: 15
STARTUP
Xyphos Biosciences, Inc.
California, United States
Patent: 12
Rush University Medical Center
Illinois, United States
Patent: 6
Sysmex Corp.
Hokkaido, Japan
Patent: 4
Novartis AG
Basel-Stadt, Switzerland
Patent: 3
Hangzhou Jiusheng Biotechnology Co., Ltd.
Zhejiang Sheng, China
Patent: 2
Suzhou Tongqian Medical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Weifang Medical University
Shandong Sheng, China
Patent: 1
Xi'an Jiaotong University
Shaanxi Sheng, China
Patent: 1
Beijing Zhengbo Weiye Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 10 patents, we discovered top 5 universities and scientific research institutions by total patent application. Korea Institute of Science & Technology, The Rockefeller University, Xi'an Jiaotong University are dominant in this area. They take 40.00% of the total patent filing.
Korea Institute of Science & Technology
South Korea
Patent: 2
The Rockefeller University
New York, United States
Patent: 1
Xi'an Jiaotong University
Shaanxi Sheng, China
Patent: 1
University of Tokyo
Tokyo-to, Japan
Patent: 1
Weifang Medical University
Shandong Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: